个人简历 | (1)受教育经历 (1)2014-9至2018-6,苏州大学,小儿骨科,博士,导师:王晓东 教授 (2)2007-9至2010-6,南京大学,关节外学,硕士,导师:蒋青 教授 (3)2002-9至2007-7,扬州大学,临床医学,学士
(2)工作经历 (1)2021-4至今 苏州大学附属儿童医院张家港医学中心 儿外科 行政主任 (2)2020-7至2021-4,苏州大学,附属儿童医院骨科,副主任医师 (3)2014-7至2020-6,苏州大学,附属儿童医院骨科,主治医师 (4)2010-7至2014-5,苏州大学,附属儿童医院骨科,医师
|
学术成果 | [1]Lun-qing Zhu1,Yun-fang Zhen*, Ya Zhang, Zhi-xiong Guo, Jin Dai, Xiao-dong Wang*, Salinomycin Activates AMP-Activated Protein KinaseDependent Autophagy in Cultured Osteoblastoma Cells: A Negative Regulator against Cell Apoptosis,PloSOne, 8(12):e84175, 2013. [2]Lun-qing Zhu1, Dong-quan Shi, Jin Dai, Jiang-hui Qin, Jian-bo Fan, Zu-yu Wang, Xu-sheng Qiu, Zhi-hong Xu, Dong-yang Che, Qing Jiang*. Lack of evidence for association between DVWA gene polymorphisms and developmental dysplasia of the hip in Chinese Han population, Rheumatol Int, 31(7):883-887,2011 [3] Yun-Rong Zhu1, Xiao-zhong Zhou,Lun-qing Zhu,, Chen Yao4, Jian-Feng Fang1,Feng Zhou1, Xiong-Wei Deng, Yun-Qing Zhang , The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models, Oncotarget, 7(31): 49527-38, 2016 [4]Yun-fang Zhen, Song-tao Li, Yun-rong Zhu,Xiao-dong Wang, Xiao-zhong Zhou,Lun-qing Zhu.Identifcationof DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells Oncotarget, 7(48): 79417 -27, 2016 [5]Zhu LQ, Su GH, Dai J, Zhang WY, Yin CH, Zhang FY, Zhu ZH, Guo ZX, Fang JF, Zou CD, Chen XG, Zhang Y, Xu CY, Zhen YF, Wang XD. Whole genome sequencing of pairwise human subjects reveals DNA mutations specific to developmental dysplasia of the hip. Genomics. 2019 May;111(3):320-326. [6] Hua-Jian Shan,Lun-Qing Zhu,Chen Yao,Zhi-Qing Zhang4,Yuan-Yuan Liu5,Qin Jiang6,Xiao-Zhong Zhou1,Xiao-Dong Wang2,Cong Cao4,7MAFG-driven osteosarcoma cell progressionis inhibited by a novel miRNA miR-4660. Mol Ther Nucleic Acids ,2021Mar 13;24:385-402 |